Industrial Alliance Investment Management Inc. Ascendis Pharma A/S Transaction History

Industrial Alliance Investment Management Inc.

$196 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$78.08 - $117.61 $21,003 - $31,637	-269 Reduced 7.28%	3,428 $319,000
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $406,720 - $542,912	3,200 Added 643.86%	3,697 $497,000
Q4 2021 Feb 10, 2022	BUY	$127.1 - $169.66 $63,168 - $84,321	497 New	497 $3.7 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

Ra Capital Management, L.P. Boston, MA

9.71M
Shares

$1.32 Billion
20.22% of portfolio
Westfield Capital Management CO LP Boston, MA

5.13M
Shares

$700 Million
3.62% of portfolio
Avoro Capital Advisors LLC New York, NY

4.99M
Shares

$680 Million
11.21% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.41M
Shares

$602 Million
1.03% of portfolio
Janus Henderson Group PLC London, X0

4.19M
Shares

$571 Million
0.33% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Industrial Alliance Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Industrial Alliance Investment Management Inc. with notifications on news.

Account